Zelicapavir
Zelicapavir (RSV-IN-7) (example 253) is an orally active RSV inhibitor (EC50: [1].
Product Specifications
CAS Number
[2070852-76-3]
Product Name Alternative
EDP-938; RSV-IN-7
UNSPSC
12352005
Target
RSV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/zelicapavir.html
Concentration
10mM
Purity
99.10
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
FC(F)(C1=CC(N2CCOCC2)=C(C3=NN=C(N[C@H]4N=C(C5=CC=CC=C5)C6=CC=CC=C6NC4=O)O3)N=C1)F
Molecular Formula
C27H22F3N7O3
Molecular Weight
549.50
References & Citations
[1]Shook Brian C., et al. Preparation of benzodiazepine derivatives for use as RSV inhibitors. Patent. WO2017015449 A1. |[2]Rhodin MHJ, et al., EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model. PLoS Pathog. 2021 Mar 15;17 (3) :e1009428.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items